This is a short article about the Hepatitis B erradication programme in the Americas, particular emphasis being placed on world and continental panoramas, followed by identification of activities adopted at continental level to achieve its erradication. The implications of the economic and epidemiological surveillance aspects of hepatitis B are presented. The American hepatitis control programme's weaknesses, opportunities, strengths and menaces are also analysed.
